FIELD: medicine, pharmaceutics.
SUBSTANCE: drug for respiratory diseasescontains a basidiomycetes extract, herbal proteolytic enzyme Bromeline, succinic acid, rutin and calcium stearate in the following ratio (wt %): proteolytic enzyme Bromeline - 3-10; edible basidiomycetes extract - 20-25; rutin (vitamin) - 20-25; succinic acid - 40-50; calcium stearate - the rest. As the basidiomycetes extract, it contains hiratake extract, shiitake mushroom extract or reishi extract. The drug Glucaferon® has an integrated effect on a body, allows essentially increasing anti-infective properties. It can be used both independently, and with underlying conventional therapy with using antiviral preparations or antibiotics.
EFFECT: invention refers to medicine, namely to pathogenetic preparations for infectious respiratory diseases produced of natural herbal raw material.
4 cl, 5 tbl, 5 ex, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION WITH ANTI-INFECTIOUS ACTIVITY | 2012 |
|
RU2476205C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF VIRAL DISEASES | 2010 |
|
RU2438694C1 |
| PREPARATION FOR TREATMENT AND PROPHYLAXIS OF VIRAL DISEASES | 2000 |
|
RU2185822C2 |
| AGENT FOR PROPHYLAXIS AND TREATMENT OF VIRAL AVIAN INFLUENZA | 2005 |
|
RU2283126C1 |
| ANTIVIRAL AGENT FOR PREVENTING AND TREATING TICK-BORNE ENCEPHALITIS | 2010 |
|
RU2444363C2 |
| WOUND-HEALING, ANTI-INFLAMMATORY AND ANTI-INFECTIOUS MEDICINAL PREPARATION | 2000 |
|
RU2173155C1 |
| AGENT RAISING SURVIVAL AND ALLEVIATING THE COURSE OF VIRAL INFECTION - EXTROMELIA IN EXPERIMENT | 1992 |
|
RU2043115C1 |
| PREPARATION FOR PREVENTING INFLUENZA | 2003 |
|
RU2252774C1 |
| METHOD OF BIOLOGICALLY ACTIVE SUBSTANCE OLIPIFAT MANUFACTURE | 2008 |
|
RU2365377C1 |
| VACCINE FOR PREVENTION AND TREATMENT OF ROTAVIRAL INFECTION CONTAINING HYBRID PROTEIN AS ACTIVE AGENT (VERSIONS) | 2013 |
|
RU2539913C2 |
